NMN and senolytics have become the most commonly combined longevity intervention pair, partly because their mechanisms are complementary and partly because human evidence exists for both. The combination addresses what many aging researchers consider the two most tractable hallmarks of aging: NAD+ decline and senescent cell accumulation.

Should I take NMN on senolytic burst days?

Yes. Continue NMN on burst days. There is no pharmacokinetic conflict, and maintaining NAD+ during the senolytic event may help healthy cells survive any bystander inflammatory signal from dying senescent cells.

Is NR (nicotinamide riboside) interchangeable with NMN here?

Yes. NR and NMN both effectively raise NAD+ via the salvage pathway. NR is typically lower cost per effective dose. Either works as the NAD+ component of this stack.